Some psoriasis patients may experience a reduction in shame and improvement in QOL after exposure to self-help interventions.

Researchers have reviewed the literature on biomarkers for HS to evaluate the validity of these biomarkers.

A new study evaluates vaccine hesitancy and medication changes in psoriasis during the Covid-19 pandemic.

Adult patients with moderate-to-severe AD being treated with dupilumab had lower rates of hospitalization and shorter stays.

A recent meta-analysis has suggested a link between AD and delinquent behaviours in children and adolescents in the US.

Tapinarof 1% cream was superior to vehicle control in reducing the severity of plaque psoriasis over a 12 week period, new study shows.

Higher doses of upadacitinib show added benefits for adults with moderate-to-severe AD when compared to dupilumab, according to a new study.

According to a new study, adults with AD have a higher incidence of systemic, autoimmune, and psychiatric comorbidities than those without.